Abstract:Objective To evaluate the clinical results of treatment for osteosarcoma of the extremities with adjuvant chemotherapy regimen Methods Sixty seven patients with ⅡB extremity osteosarcoma were treated with the combination of adjuvant chemotherapy regimen and definitive surgery Forty seven of them were male and twenty four were female The mean age of the patients at the time of diagnosis was 20 years (ranged 10～51 years) Sixty four lesions involved the lower extremity, with 45 involving the distal femur, 14 the upper tibia, 3 the upper fibula and 2 the proximal femur; Three involved the upper end of the humerus The study of subtype of osteosarcoma revealed that 51 were osteoblastic, 6 chondroblastic, 5 fibroblastic and 5 the other subtypes The patients were divided into three groups according to the adjuvant chemotherapy regimen given, the first group consisted of 23 cases, who were treated with the combination of the presurgical cisplatin hyperthermic isolated limb perfusion (CDP-HILP) and postoperative chemotherapy; the second group of 20 cases, who were treated with the combination of the presurgical CBP-HILP and postoperative chemotherapy; and the other 24 cases were treated with postoperative chemotherapy alone Twenty nine of the 67 patients treated surgically had limb salvage procedures; 35 had amputations and 3 had Tikhoff-Limbergs surgery Multiple histologic sections were procured and examined from each of the surgical specimens in the patients who were treated with preoperative HILP to determine the effect of chemotherapy All patients were followed from 3 to 9 years, and the data were statistically analeyed using SPSS 7 0 Results Among 67 cases, 41 (61 19%) had relapse free survival(RFS) in 2 years after surgery, 37 (55 22%) had RFS in 3 years after surgery, and RFS probability at 5 years after surgery was 49 56% Log-rank analysis showed no significant difference in RFS probability among the three groups(P=0 517 1), but there was a significant difference in RFS probability between patients who had limb salvage procedure and those had amputation(P=0 009 7) Age, sex, site and subtype were not significant prognostic variables in this group of patients Correction analysis revealed that the RFS probability were not related with the rate of the tumor necrosis (P=0 058) Conclusion The data revealed that 1) The chemotherapy regimen mainly including platinic drugs was effective treatment for osteosarcoma ,and was more simple and less expensive than any previous reported chemotherapy for steosarcoma, 2) CDP of chemotherapy regimen for osteosarcoma, which had more nephritic and audio toxicity could be replaced by CBP , And 3)Whether the preoperative chemotherapy is suitable for the patients in whom amputation is inevitable (based on age ,size, and involvement of local structure) remains unclear

Surgical Treatment and Prognostic Analysis of Osteosarcoma in Adults Older Than 40 Years

The diuleal features and prognostic factors of osteosarcoma in adult

The Treatment of Stage III Osteosarcoma

The clinical features and prognostic factors of osteosarcoma in adult.

Characteristics and Prognostic Factors of Patients with Osteosarcoma Older Than 60 Years from the SEER Database

COX Proportional-Hazard Regression Analysis of Prognostic Factors in 52 Adult Patients with Osteosarcoma

Clinical features and prognosis of osteosarcoma in elderly patients

Clinicopathologic features of primary osteosarcoma in adults: A report of 98 patients over 30 years of age

Survival Analysis of 311 Patients with Osteosarcoma of the Extremities Treated in a Single Institute

Retrospective Analysis of Clinical Differences between Preadolescent and Young Adult Patients with Osteosarcoma and Their Prognostic Factors

Retrospective analysis of clinical differences and prognostic factors in 32 patients with maxillofacial osteosarcoma

The Role of Chemotherapy in the Survival Benefits of Patients Aged Older Than 40 Years With Osteosarcoma

Osteosarcoma in Elderly Patients: a Report of 10 Cases

The assessment of the effectiveness of the adjuvant chemotherapy regimen for the treatment of osteosarcoma

Prognostic Factors in Osteosarcoma: A Study Level Meta-Analysis and Systematic Review of Current Practice

[Prognostic Factors for 72 Patients with Osteosarcoma of the Extremity Treated with Neoadjuvant Chemotherapy].

Clinical Factors Affecting Prognosis of Limb Osteosarcoma in China: a Multicenter Retrospective Analysis.

Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.

Ten-year follow-up of the chemotherapy,surgery and prognosis for 413 cases of osteosarcoma

Outcome of Patients with Osteosarcoma after Recurrence and Analysis of Factors Affecting the Long-Term Survival——a Long-Term Follow-Up Study of Recurrent Patients by Multicenter

Analysis of prognostic factors for osteosarcoma of the flat bone and irregular bone